Pharma news
Americas
Merck Sharp & Dohme has filed a lawsuit against Genentech asking the US District Court for the Central District of California to re-evaluate a patent belonging to Genentech. 11 July 2016
Asia
Healthcare provider Zydus Cadila has signed a sub-licensing agreement with the Medicines Patent Pool (MPP) centring on the generic production of Daklinza (daclatasvir). 8 July 2016
Pharma
The Court of Justice of the European Union has said the beneficiary of a patent licence must pay the agreed royalty rate even if it does not infringe the patented technology. 7 July 2016
Americas
Law firm Jones Day has hired John Wehrli as a partner in the firm’s intellectual property practice in San Diego. 7 July 2016
Pharma
Following the UK’s vote to leave the EU, it is business as usual for life sciences companies working with intellectual property, at least for now, says Claire Phipps-Jones of Bristows. 7 July 2016
Americas
Pharmaceutical company Bristol-Myers Squibb has acquired Cormorant Pharmaceuticals in a deal valued at up to $95 million. 6 July 2016
Pharma
The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties. 5 July 2016
Asia
Pfizer has revealed that it will invest approximately $350 million to develop a Global Biotechnology Center in China. 5 July 2016
Americas
Pharmaceutical company Teva and US-based Antares Pharma have launched a generic version of Imitrex, which is used to treat migraines. 4 July 2016
Americas
Genzyme has sued Zydus Pharmaceuticals in a lawsuit that claims that the company has infringed two of its patents. 1 July 2016